SilverArc Private — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
ADARx Pharmaceuticals, Inc.Aug 2023SEC filingmedium confidence
San Diego, US
Board seatSheila Gujrathi· per SEC Form D · $200M raise · filed Aug 2023
Lila Biologics, Inc.Sep 2023SEC filingmedium confidence
BiotechSeattle, US
William Canestaro(Director)Sheila Gujrathi(Director)John Kraft, II(Executive Officer, Director)Anindya Roy(Executive Officer, Director)
Board seatSheila Gujrathi· per SEC Form D · $10.6M raise · filed Sep 2023
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.